Genetics and the Dutch Hypothesis

Chronic Respiratory Disease

Volumn 1, Issue 2, 2004, Pages 105-113

  Ruse, C E ^a   Parker, S G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

candidate genes; chronic obstructive pulmonary disease (COPD); polymorphisms

Indexed keywords

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETICS; HUMAN; REVIEW;

ASTHMA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 32944475098     PISSN: 14799723     EISSN: None     Source Type: Journal    
DOI: 10.1191/1479972304cd023rs     Document Type: Review

References (87)

1. Corder EH, Saunders AM, Strimater WJ et al. Gene dose apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
2. Elbein SC. Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology 2003; 143: 2012-2018.
3. Orie NGM, Sluiter JH, de Vries K et al. The host factor in bronchitis. In Bronchitis an international symposium, Springfield, IL: Charles C Thomas, 1961, 44-49.
4. Corrigan CJ, Kay AB. T-cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501-507.
5. Crepea SB, Harman JW. The pathology of bronchial asthma. J Allergy 1955; 26: 453-460.
6. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1922; 30: 689-760.
7. Cardell BS, Pearson RSB. Death in asthmatics. Thorax 1959; 4: 341-352.
8. Wright JL, Cagle P, Churg A et al. State of the art; disease of the small airways. Am Rev Respir Dis 1992; 146: 240-262.
9. Barbee RA, Halonen M, Lebowitz MD et al. Distribution of IgE in a community population sample: correlation with age, sex, and skin test reactivity. JAllergy Clin Immunol 1981; 68: 106-111.
10. Dow L, Coggon D, Campbell MJ et al. The interaction between Immunoglobulin E and smoking in airflow obstruction in the elderly. Am Rev Respir Dis 1992; 146: 402-402.
11. Burrows B, Martinez F, Halonan M et al. Association of asthma with serum IgE levels and skin test reactivity to allergens. N Engl J Med 1989; 20: 271-277.
12. Palmer LJ, Burton PR, Faux J et al. Independent inheritance of serum Immunoglobulin E and airway responsiveness. Am J Resp Crit Care Med 2000; 161: 1836-1843.
13. Braman SS, Kaemerlen JT, Davis SM. Asthma in the elderly: a comparison between patients with recently acquired and long-standing disease. Am Rev Respir Dis 1991; 143: 336-340.
14. Barbee RA, Halone M, Kaltenborn W et al. A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking and atopic status. J Allergy Clin Immunol 1987; 79: 919-927.
15. Vollmer WM, Buist SA, Johnson LR et al. Relationship between serum IgE and cross-sectional and longitudinal FEVI in two cohort studies. Chest 1986; 90: 416-423.
16. Gerrard JW, Heiner DC, Ko CG et al. Immunoglobulin levels in smokers and non-smokers. Ann Allerg 1980; 44: 261-262.
17. Burrows B, Halonen M, Barbee RA et al. The relationship of serum immunoglobulin E to cigarette smoking. Am Rev Respir Dis 1981; 124: 523-525.
18. Pride NB, Vermiere P, Allegra L. Diagnostic labels applied to model case histories of chronic airflow obstruction. Responses to a questionnaire in 1 1 North American and Western European Countries. Eur Respir J 1989; 2: 702-709.
19. Burrows B, Bloor JW, Traver GA et al. The course and prognosis of different forms of chronic airflow obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309-1314.
20. Lee HY, Stretton TB. Asthma in the elderly. Brit Med J 1972; 4: 93-95.
21. Burr M, Charles T, Roy KL et al. Asthma in the elderly; an epidemiological survey. Brit Med J 1979; 1(6170): 1041-1044.
22. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Brit Med J 1976; 1(6077): 1645-1648.
23. Fletcher C, Peto R, Tinker C et al. The natural history of chronic bronchitis: an eight year follow up study of working men in London. Oxford: Oxford University Press, 1976.
24. Burrows B, Knudson RJ, Cline MG et al. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977; 115: 195-205.
25. Louis PCA. Recherchs sur l'emphyseme des poumers. Meme Soc Med Obs 1837; 1: 160-261.
26. Anonymous. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52: S1-S28.
27. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131-136.
28. Givelber RJ, Couropmitree NN, Gottleib DJ et al. Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med 1998; 157: 1445-1451.
29. Tager IB, Rosner B, Tishler PV et al. Household aggregation of pulmonary function and chronic bronchitis. Am Rev Respir Dis 1976; 114: 485-492.
30. Chen Y, Home SL, Rennie DC et al. Segregation analysis of two lung function indices in a random sample of young families: the Humbolt Family Study. Genet Epidemiol 1996; 13: 35-47.
31. Coultas DB, Hanis CL, Howard CA et al. Heritability of ventilatory function in smoking and non-smoking New Mexico Hispanics. Am Rev Respir Dis 1991; 144: 770-775.
32. Larson RK, Barman ML, Kueppers et al. Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Int Med 1970; 72: 627-632.
33. Cohen BH, Diamond EL, Graves GC. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 1977; ii: 523-526.
34. Rybrick BA, Beaty TH, Cohen BH. Major genetic mechanism in pulmonary function. J Clin Epidemiol 1990; 43: 667-675.
35. Sibbald B, Turner-Warwick M. Factors influencing the prevalence of asthma among first-degree relatives of extrinsic and intrinsic asthmatics. Thorax 1979; 34: 332-337.
36. Ruse CE, Parker SG. Molecular genetics and age related disease. Age Ageing 2001; 30: 449-454.
37. Daniels SE, Bhattacharrya S, James A. A genome wide search for quantitative trait loci underlying asthma. Nature 1996; 383: 247-250.
38. CSGA. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nature Genetics 1997; 15: 389-392.
39. Ober C, Cox N, Parry R et al. Genome wide screen for asthma susceptibility loci in a founder population. Hum Molec Genet 1998; 7: 1393-1393.
40. Wjst M, Fischer G, Immervoll T et al. A genome wide search for linkage to asthma. Genomics 1999; 58: 1-8.
41. Diezer MH. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000; 162: 1812-1818.
42. Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418: 426-430.
43. Silverman EK, Palmer LJ Mosley JD et al. Genome-wide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70: 1229-1239.
44. Joost O, Wilk JB, Cupples LA et al. Genetic loci influencing lung function: a genome wide scan in the Framingham study. Am J Respir Crit Care Med 2002; 165: 795-799.
45. Wilson AG, Symons JA, McDowell TL. Effects of a polymorphism in the human tumour necrosis factor gene on transcriptional activation. Proc Natl Acad Sci 1997; 94: 391-399.
46. Louis E, Franchimont D, Piron A. Tumour necrosis factor gene polymorphism influences TNFa production in LPS stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406.
47. Kips JC, Tavemier JH, Joos GF. The potential role of tumour necrosis factor alpha in asthma. Clin Exp Allergy 1993; 23: 247-250.
48. Keating VM, Collins, PD, Scott DP et al. Differences in IL-8 and TNF in induced sputum from patients with COPD or asthma. Am J Respir Crit Care Med 1996; 152: 1646-1652.
49. Ide Godoy, Donahoe M, Calhoun WJ, Elevated TNF alpha production by peripheral blood monocytes in weight losing COPD patients. Am J Respir Crit Care Med 1996; 153: 633-637.
50. Moffat MF, Cookson WOCM. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-554.
51. Albuquerque RV, Hayden CM, Palmer LJ et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy 1998; 28: 578-584.
52. Huang SL, Su CH, Chang SC. Tumour necrosis factor gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436-1439.
53. Sakao S, Tatsumi K, Igari H et al. Association of TNFa gene promotor polymorphism with COPD. Am J Respir Crit Care Med 2001; 163: 420-423.
54. Patuzzo C, Gile LS, Zorzetto M et al. Tumour necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000; 117: 1353-1358.
55. Higham MA, Pride NB, Alikham A. Tumour necrosis polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 281-284.
56. Keating VM, Cave SJ, Henry M. A polymorphism in the TNF gene promoter region may predispose to a poor prognosis in patients with COPD. Chest 2000; 118: 971-975.
57. Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum IgE concentrations. Science 1994; 264: 1152-1156.
58. Postma D, Bleecker E, Amelung P et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness co-inherited with a major gene for atopy. N Engl J Med 1995; 337: 894-900.
59. Doull IJM, Lawrence S, Watson M et al. Allelic associations of gene markers on chromosome 5q and 1 lq with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996; 153: 1280-1284.
60. Meyers DA, Postma, DS, Panhasysen CIM et al. Evidence for a locus regulating total serum IgE levels maps to chromosome 5. Genomics 1994; 23: 464-470.
61. Johnson M. Mechanisms of action of, B-adrenoceptor agonists. In Costello JF, Mann RD eds. Beta agonists in the treatment of asthma. Carnforith, UK: Parthenon, 1992: 27-42.
62. Johnson M, Coleman RA. Mechanisms of action of beta-2-adrenoceptor agonists. In Busse WW, Holgate ST eds. Asthma and rhinitis. Cambridge, UK: Blackwell, 1995: 1276-1295.
63. Chong LK, Chowdy J. Ghahramani et al. Influence of genetic polymorphisms in the beta-2-adrenoceptor on desensitisation in human mast cells. Pharmacogenetics 2000; 10: 153-162.
64. Reihsaus E, Innis M, Maclntyre N et al. Mutations in the gene coding for the 3-2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334-339.
65. Jacobs KB, Burton PR, Iyengar SK et al. Pooling data and linkage analysis in the chromosome 5q candidate region for asthma. Genet Epidemiol 2001; Suppl 1: S103-S108.
66. Anthonisen NR, Wright EC, IPPB Trial Group. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 814-819.
67. Holloway JW, Dunbar PR, Riley GA et al. Association of beta adrenoceptor polymorphisms with severe asthma. Clin Exp Allergy 2000; 30: 1097-1103.
68. Turki J, Pak J, Green SA et al. Genetic polymorphisms of the,32 adrenergic receptor in nocturnal and non-nocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95: 1635-1641.
69. Weir TD, Mallek N, Sandford AJ et al. Beta-2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158: 787-791.
70. Summerhill E, Leavitt SA, Gidley H et al. 3-2 adrenergic receptor argl6/argl6 is associated with reduced lung function, but not with asthma in the Hutterites. Am J Respir Crit Care Med 2000; 162: 599-602.
71. Dewar J, Wheatley A, Ven A et al. Beta-2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp Allergy 1998; 28: 442-448.
72. Ho L, Ham HJ, Chen CJ et al. Polymorphism of the beta adrenoceptor in COPD in Chinese subjects. Chest 2001; 120: 1493-1499.
73. Joos L, Weir TD, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Polymorphisms in the beta-2-adrenergic receptor and bronchodilator response, bronchial hyper-responsiviness, and rate of decline in lung function in smokers. Thorax 2003; 58: 703-707.
74. Wills-Karpp M, Chiaramonte M, IL-13 in asthma. Curr Opin Pul Med 2003; 9: 21-27.
75. Zheng T, Zhou Z, Wang Z et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema. J Clin Invest 2000; 106: 1081-1093.
76. Howard TD, Whittaker PA, Zaiman AL et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001; 25: 377-384.
77. van de Pouw Krann TC, van Veen A, Boeije LC et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immunol 1999; 1: 61-65.
78. He JQ, Connett JE, Anthonisen NR, Sandford AJ. Polymorphisms in the IL-13, IL-13 receptor and IL-4 receptor alpha genes and rate of decline of lung function in smokers. Am J Respir Cell Mol Biol 2003; 28: 379-385.
79. Van der Pouw-Krann TC, Kucukagcon M, Bakker FM. COPD is associated with the-1055 promoter polymorphism. Genes Immunol 2002; 3: 436-439.
80. Steine JW, Borish L. 11-4: its role in the pathogenesis of asthma and targeting it for asthma treatment with IL-4 receptor antagonists. Respir Res 2001; 2: 66-70.
81. Kabesch M, Tzotcheva I, Carr D et al. A complete screening of the IL-4 gene: novel polymorphisms and their association with asthma. JAllergy Clin Immunol 2003; 112: 893-898.
82. Beghe B, Barton S, Rorke S, Reng Q. Polymorphisms of the IL-4 and IL-4 receptor alpha chain genes confer susceptibility to asthma in a Caucasian population. Clin Exp Allergy 2003; 33: 1111-1117.
83. Lensmar C, Nord M, Gudmundsson GH et al. Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics. Cell Mol Life Sci 2000; 57: 976-978.
84. Pilette C, Godding V, Kiss R et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstructionion COPD. Am J Respir Crit Care Med 2001; 163: 185-194.
85. Laing IA, Hermans C, Bemard S, Burton PR, Glodblatt J, Le Souef PN. Association between plasma CC 16 levels, the A3C8G polymorphism and asthma. Am J Respir Crit Care Med 2000; 161: 124-127.
86. Mansur AH, Fryer AA, Hepple M, Strange RC, Spiteris MA. An association study between the Clara cell secretory protein CC 16 A38G polymorphism and asthmatic phenotype. Clin Exp Allergy 2002; 32: 994-999.
87. McLeod HL, Yu J. Cancer pharmacogenetics: SNPS, chips, and the individual patient. Cancer Invest 2003; 21: 630-640.